Recent Updates
Recently added Catalysts
AKAN Positive Sentiment Score: 70/100

Akanda Corp. Announces Pricing of Underwritten Public Offering London

Key Takeaway: Akanda Corp. has announced the pricing of an underwritten public offering, agreeing to sell 1,500,000 common shares at $1.00 per share. The offering is projected to generate approximately $1,500,000 in gross proceeds, which will be allocated toward capital expenditures, operating capacity, and potential acquisitions. The transaction is expected to close on or about October 3, 2024, pending customary closing conditions. The company emphasizes its commitment to safety and accessibility in the cannabis industry.

Market Sentiment Analysis

POSITIVE FACTORS

  • Successful pricing of an underwritten public offering.
  • Estimated gross proceeds of approximately $1,500,000.
  • Funds raised will be used for capital expenditures and operational capacity.

Full Press Release Details

Akanda Corp. Announces Pricing of Underwritten
London, October 2, 2024 - Akanda
Corp. ("Akanda" or the "Company") (NASDAQ: AKAN), an international
medical cannabis company, today announced that it has entered into a firm commitment underwriting agreement with Univest Securities, LLC,
as underwriter, whereby Univest has agreed to purchase 1,500,000 common shares (or pre-funded warrants in lieu thereof) at a public offering
price of $1.00 per share or $0.9999 per pre-funded warrant in an underwritten public offering.
The gross proceeds to Akanda are estimated to
be approximately $1,500,000 before deducting the underwriter fees and other offering expenses payable by the Company. The offering is
expected to close on about October 3, 2024, subject to the satisfaction of customary closing conditions. Akanda plans to use the net proceeds
from the offering for capital expenditures, operating capacity, working capital, potential milestone payments of the option to purchase
agreement for certain Canadian property, general corporate purposes, and the refinancing or repayment of existing indebtedness and acquisitions
of complementary products, technologies or businesses.
The securities described above are being offered
by Akanda pursuant to an effective registration statement on Form F-1, as amended (File No. 333-281945), declared effective by the U.S.
Securities and Exchange Commission ("SEC") on September 30, 2024. A final prospectus relating to the offering will be filed
with the SEC and will be available free of charge on the SEC's website at http://sec.gov.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration
requirements of the Securities Act of 1933, as amended.
Akanda Corp. is an international cannabis company
with operations in Europe and North America. The company is dedicated to cultivating and distributing high-quality medical cannabis and
wellness products that improve lives. Akanda's mission is to provide safe, reliable, and accessible cannabis products to consumers
worldwide while promoting sustainable business practices.
Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram
Cautionary Note Regarding Forward-Looking
Information and Statements
This press release contains certain "forward-looking
information" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition,
but instead represent only Akanda's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently
uncertain and outside of Akanda's control. Generally, such forward-looking information or forward-looking statements can be identified
by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is
expected", "budget", "scheduled", "estimates", "forecasts", "intends",
"anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or
may contain statements that certain actions, events or results "may", "could", "would", "might"
or "will be taken", "will continue", "will occur" or "will be achieved" and similar expressions
and include statements regarding the timing and completion of the proposed offering. Forward-looking information may relate to anticipated
events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking
information and forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does
not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except
in accordance with applicable securities laws.

Frequently Asked Questions

What is the public offering price of Akanda's shares?

The public offering price of Akanda's shares is $1.00 each.

How many shares is Akanda offering?

Akanda is offering 1,500,000 common shares in this offering.

What will Akanda use the proceeds for?

The proceeds will be used for capital expenditures, working capital, and debt repayment.

When is the offering expected to close?

The offering is expected to close on or about October 3, 2024.

Where can the final prospectus be accessed?

The final prospectus will be available on the SEC's website at http://sec.gov.

Last updated: Oct 2, 2024